home_banner_desktop_2x_new home_banner_mobile

Get back to living with SENVELGO® (velagliflozin oral solution)

The convenient, once-daily liquid oral solution for feline diabetes.

The easy choice

Managing feline diabetes might feel overwhelming at first — but it doesn’t have to be.
SENVELGO® (velagliflozin oral solution) is a once-daily, liquid oral treatment that helps many cat owners like you care for your cats with confidence and ease. In fact, a study showed that 89.1% of cats achieved successful outcomes with SENVELGO®

Once-a-day and on your way

With once-daily dosing that takes the hassle out of treatment, you and your cat can get back to what you love most — from cozy cuddles to carefree cat naps.

SENVELGO®

(velagliflozin oral solution)

The benefits of SENVELGO®:

  • Once-daily dosing<sup>1</sup>

    Once-daily dosing1

  • Convenient liquid formula

    Convenient liquid formula

  • Well-accepted by cats<sup>2</sup>

    Well-accepted by cats2

  • Easy & accurate dosing

    Easy & accurate dosing

  • No refrigeration required<sup>1</sup>

    No refrigeration required1

  • Needle-free oral solution

    Needle-free oral solution

medicine

Why Choose SENVELGO® oral solution?

 

Success Stories From Owners Like You

Cat owners share the unique experiences of their cat's diabetes diagnosis and treatment with SENVELGO® oral solution.

Image
cat

Education Hub

Explore essential resources on diabetes in cats, diabetic ketoacidosis (DKA), and treatment approaches. 

Is Your Cat at Risk for Diabetes?

Image
cat

Talk to Your Vet

Discuss your cat's diabetes management and treatment plan with your vet to see if there is an easier solution.

Important Safety Information

SENVELGO® (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin.

Before using this product, it is important to read the entire product insert, including the boxed warning.


Cats treated with SENVELGO® may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death.

Development of these conditions should be treated promptly, including insulin administration and discontinuation of SENVELGO®.


Do not use SENVELGO® in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus.

The use of SENVELGO® in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO®, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death.


Sudden onset of hyporexia/anorexia, lethargy, dehydration, or weight loss in cats receiving SENVELGO® should prompt immediate discontinuation of SENVELGO® and assessment for diabetic ketoacidosis, regardless of blood glucose level.

SENVELGO® should not be initiated in cats with ketonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis.

Keep SENVELGO® in a secure location out of reach of children, dogs, cats, and other animals to avoid accidental ingestion or overdose. 

For more information, please see full prescribing information.